GH
Price
$44.42
Change
-$1.07 (-2.35%)
Updated
Jul 25 closing price
Capitalization
2.46B
3 days until earnings call
NEPH
Price
$3.57
Change
+$0.13 (+3.78%)
Updated
Jul 25 closing price
Capitalization
23.09M
10 days until earnings call
Interact to see
Advertisement

GH vs NEPH

Header iconGH vs NEPH Comparison
Open Charts GH vs NEPHBanner chart's image
Guardant Health
Price$44.42
Change-$1.07 (-2.35%)
Volume$1.44M
Capitalization2.46B
Nephros
Price$3.57
Change+$0.13 (+3.78%)
Volume$22.95K
Capitalization23.09M
GH vs NEPH Comparison Chart in %
Loading...
GH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GH vs. NEPH commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GH is a StrongBuy and NEPH is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (GH: $44.42 vs. NEPH: $3.57)
Brand notoriety: GH: Notable vs. NEPH: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: GH: 72% vs. NEPH: 49%
Market capitalization -- GH: $2.46B vs. NEPH: $23.09M
GH [@Medical Specialties] is valued at $2.46B. NEPH’s [@Medical Specialties] market capitalization is $23.09M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GH’s FA Score shows that 0 FA rating(s) are green whileNEPH’s FA Score has 0 green FA rating(s).

  • GH’s FA Score: 0 green, 5 red.
  • NEPH’s FA Score: 0 green, 5 red.
According to our system of comparison, NEPH is a better buy in the long-term than GH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GH’s TA Score shows that 5 TA indicator(s) are bullish while NEPH’s TA Score has 3 bullish TA indicator(s).

  • GH’s TA Score: 5 bullish, 4 bearish.
  • NEPH’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, GH is a better buy in the short-term than NEPH.

Price Growth

GH (@Medical Specialties) experienced а -4.39% price change this week, while NEPH (@Medical Specialties) price change was -2.06% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.01%. For the same industry, the average monthly price growth was +4.92%, and the average quarterly price growth was -2.24%.

Reported Earning Dates

GH is expected to report earnings on Oct 30, 2025.

NEPH is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Medical Specialties (+3.01% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GH($2.47B) has a higher market cap than NEPH($23.1M). NEPH YTD gains are higher at: 142.857 vs. GH (45.401). NEPH has higher annual earnings (EBITDA): -1.36M vs. GH (-433.3M). GH has more cash in the bank: 1.17B vs. NEPH (4.31M). NEPH has less debt than GH: NEPH (1.84M) vs GH (1.35B). GH has higher revenues than NEPH: GH (564M) vs NEPH (14.2M).
GHNEPHGH / NEPH
Capitalization2.47B23.1M10,671%
EBITDA-433.3M-1.36M31,884%
Gain YTD45.401142.85732%
P/E RatioN/AN/A-
Revenue564M14.2M3,972%
Total Cash1.17B4.31M27,142%
Total Debt1.35B1.84M73,747%
FUNDAMENTALS RATINGS
GH vs NEPH: Fundamental Ratings
GH
NEPH
OUTLOOK RATING
1..100
5772
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
71
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10072
PRICE GROWTH RATING
1..100
6137
P/E GROWTH RATING
1..100
10098
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GH's Valuation (66) in the Medical Or Nursing Services industry is in the same range as NEPH (71) in the null industry. This means that GH’s stock grew similarly to NEPH’s over the last 12 months.

GH's Profit vs Risk Rating (100) in the Medical Or Nursing Services industry is in the same range as NEPH (100) in the null industry. This means that GH’s stock grew similarly to NEPH’s over the last 12 months.

NEPH's SMR Rating (72) in the null industry is in the same range as GH (100) in the Medical Or Nursing Services industry. This means that NEPH’s stock grew similarly to GH’s over the last 12 months.

NEPH's Price Growth Rating (37) in the null industry is in the same range as GH (61) in the Medical Or Nursing Services industry. This means that NEPH’s stock grew similarly to GH’s over the last 12 months.

NEPH's P/E Growth Rating (98) in the null industry is in the same range as GH (100) in the Medical Or Nursing Services industry. This means that NEPH’s stock grew similarly to GH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GHNEPH
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
64%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 17 days ago
79%
Bullish Trend 9 days ago
76%
Declines
ODDS (%)
Bearish Trend 9 days ago
83%
Bearish Trend 5 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
GH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GPI436.5220.46
+4.92%
Group 1 Automotive
RCKY23.840.50
+2.14%
Rocky Brands
HSY187.123.22
+1.75%
Hershey Company (The)
CVKD11.490.08
+0.70%
Cadrenal Therapeutics Inc
OPK1.37-0.03
-2.14%
OPKO Health

GH and

Correlation & Price change

A.I.dvisor indicates that over the last year, GH has been loosely correlated with TWST. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if GH jumps, then TWST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GH
1D Price
Change %
GH100%
-2.35%
TWST - GH
49%
Loosely correlated
+2.59%
NTRA - GH
47%
Loosely correlated
-1.53%
VCYT - GH
46%
Loosely correlated
+7.04%
RGEN - GH
42%
Loosely correlated
-0.11%
BLFS - GH
40%
Loosely correlated
+1.44%
More

NEPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEPH has been loosely correlated with SGHT. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if NEPH jumps, then SGHT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEPH
1D Price
Change %
NEPH100%
+3.78%
SGHT - NEPH
34%
Loosely correlated
-1.97%
GH - NEPH
28%
Poorly correlated
-2.35%
AZTA - NEPH
25%
Poorly correlated
+1.38%
NEO - NEPH
24%
Poorly correlated
-2.02%
TNDM - NEPH
24%
Poorly correlated
+2.91%
More